Warren Buffett - Berkshire Hathaway Inc
Holding/activity history for Glaxosmithkline Plc (AP47)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2013 Q4 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2013 Q3 | 345,819 | 0.02 | Reduce 76.57% | 0.06 | $50.17 | $17,350,000 | SEC |
| 2013 Q2 | 1,476,021 | 0.08 | Reduce 2.28% | <0.01 | $49.97 | $73,757,000 | SEC |
| 2013 Q1 | 1,510,500 | 0.08 | $46.91 | $70,858,000 | SEC | ||
| 2012 Q4 | 1,510,500 | 0.09 | $43.47 | $65,661,000 | SEC | ||
| 2012 Q3 | 1,510,500 | 0.09 | $46.24 | $69,846,000 | SEC | ||
| 2012 Q2 | 1,510,500 | 0.10 | $45.57 | $68,833,000 | SEC | ||
| 2011 Q4 | 1,510,500 | 0.11 | $45.63 | $68,924,000 | SEC | ||
| 2011 Q3 | 1,510,500 | 0.11 | $41.29 | $62,369,000 | SEC | ||
| 2011 Q2 | 1,510,500 | 0.13 | $42.90 | $64,800,000 | SEC | ||
| 2011 Q1 | 1,510,500 | 0.11 | $38.41 | $58,018,000 | SEC | ||
| 2010 Q4 | 1,510,500 | 0.11 | $39.22 | $59,242,000 | SEC | ||
| 2010 Q3 | 1,510,500 | 0.12 | $39.52 | $59,695,000 | SEC | ||
| 2010 Q2 | 1,510,500 | 0.11 | $34.01 | $51,372,000 | SEC | ||
| 2010 Q1 | 1,510,500 | 0.12 | $38.52 | $58,184,000 | SEC | ||
| 2009 Q4 | 1,510,500 | 0.11 | $42.25 | $63,819,000 | SEC | ||
| 2009 Q3 | 1,510,500 | 0.11 | $39.51 | $59,680,000 | SEC | ||
| 2009 Q2 | 1,510,500 | 0.11 | $35.34 | $53,381,000 | SEC | ||
| 2009 Q1 | 1,510,500 | 0.12 | $31.07 | $46,931,000 | SEC | ||
| 2008 Q4 | 1,510,500 | 0.11 | $37.27 | $56,296,000 | SEC | ||
| 2008 Q3 | 1,510,500 | 0.12 | $43.46 | $65,646,000 | SEC | ||
| 2008 Q2 | 1,510,500 | 0.12 | $44.22 | $66,794,000 | SEC | ||
| 2008 Q1 | 1,510,500 | 0.10 | $42.43 | $64,091,000 | SEC | ||
| 2007 Q4 | 1,510,500 | 0.11 | Buy | 0.11 | $50.39 | $76,114,000 | SEC |